Arthur J. Gallagher stock price target raised to $347 by Goldman Sachs

Goldman Sachs raised its price target on Arthur J. Gallagher (AJG) to $347, maintaining a Buy rating, citing a solid mid-quarter update, maintained organic growth guidance slightly above consensus, and significantly increased synergy projections for its AssuredPartners acquisition to $270 million. This positive outlook, which includes an estimated 19% total return opportunity and high-single-digit EPS accretion from strategic acquisitions, comes despite AJG recently missing Q2 2025 earnings and revenue forecasts. The firm's strategic expansion through its largest-ever acquisition of AssuredPartners is expected to drive long-term growth, prompting Goldman to increase its 2027 Brokerage adjusted EBITDAC margin estimate by 30 basis points.

Analysis

Goldman Sachs has raised its price target on Arthur J. Gallagher (AJG) to $347.00, maintaining a Buy rating, signaling confidence in the firm's forward-looking prospects despite a recent quarterly miss. The positive revision is underpinned by a mid-quarter update that was viewed as better than feared, with management reaffirming Q3 2025 guidance and projecting full-year 2025 Brokerage organic growth of 6.5%, slightly ahead of the 6.4% consensus. The most significant driver of this optimism is the acquisition of AssuredPartners, for which AJG has increased its synergy guidance midpoint to $270 million, a substantial jump from the previous $160 million. This has led Goldman Sachs to increase its 2027 Brokerage adjusted EBITDAC margin estimate by 30 basis points and project a 19% total return opportunity. This bullish outlook, however, contrasts with AJG's reported Q2 2025 results, where both adjusted EPS ($2.33) and revenue ($3.17 billion) fell short of analyst forecasts. The market backdrop shows modest improvement, with property renewal premiums improving to -5% while casualty rates decelerated to +7%, highlighting a mixed but manageable pricing environment.

Key Decisions for Investors

• Investors should weigh the significant long-term accretion potential from the AssuredPartners acquisition, particularly the upgraded synergy guidance of $270 million, which forms the core of the bullish thesis and Goldman Sachs's projected 19% total return.
• It is critical to balance the positive forward guidance against the company's recent Q2 2025 earnings and revenue miss, which introduces an element of execution risk to the optimistic outlook.
• Monitor upcoming quarterly reports for evidence that the projected 6.5% organic growth and improved EBITDAC margins are materializing, as these are key validations for the M&A-driven growth narrative.